Expression of β-galactoside α2,6 sialyltransferase and of α2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis

Glycobiology

Volumn 14, Issue 1, 2004, Pages 39-49

  Dall'Olio, Fabio ^a   Chiricolo, Mariella ^a   D'Errico, Antonia ^a   Gruppioni, Elisa ^a   Altimari, Annalisa ^a   Fiorentino, Michelangelo ^a   Grigioni, Walter F ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cirrhosis; Hepatocarcinoma; Liver; Sambucus nigra agglutinin; Sialyltransferases

Indexed keywords

BETA GALACTOSIDE ALPHA2,6 SIALYLTRANSFERASE I; GLYCOCONJUGATE; GLYCOPROTEIN; LECTIN; MESSENGER RNA; SIALIC ACID DERIVATIVE; SIALYLTRANSFERASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GRADING; CELL LEVEL; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SAMBUCUS NIGRA; SEX DIFFERENCE; SIALYLATION; TISSUE HOMOGENATE; UPREGULATION;

AGED; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RNA, MESSENGER; SIALYLTRANSFERASES; TRANSCRIPTION, GENETIC;

SAMBUCUS; SAMBUCUS NIGRA;

EID: 0742306881     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/cwh002     Document Type: Article

References (46)

1. Aas-Eng, D.A., Asheim, H.C., Deggerdal, A., Smeland, E., and Funderud, S. (1995) Characterization of a promoter region supporting transcription of a novel human β-galactoside α-2,6-sialyltransferase transcript in HepG2 cells. Biochim. Biophys. Acta, 1261, 166-169.
2. Appenheimer, M.M., Huang, R.Y., Chandrasekaran, E.V., Dalziel, M., Hu, Y.P., Soloway, P.D., Wuensch, S.A., Matta, K.L., and Lau, J.T. (2003) Biologic contribution of P1 promoter-mediated expression of ST6Gal I sialyltransferase. Glycobiology, 13, 591-600.
3. Cao, Y., Merling, A., Crocker, P.R., Keller, R., and Schwartz-Albiez, R. (2002) Differential expression of beta-galactoside alpha2,6 sialyltransferase and sialoglycans in normal and cirrhotic liver and hepatocellular carcinoma. Lab Invest., 82, 1515-1524.
4. Dall'Olio, F. (1996) Protein glycosylation in cancer biology: an overview. Clin. Molec. Pathol., 49, M123-M126.
5. Dall'Olio, F. (2000) The sialyl-α2,6-lactosaminyl-structure: biosynthesis and functional role. Glycoconj. J., 17, 669-676.
6. Dall'Olio, F. and Chiricolo, M. (2001) Sialyltransferases in cancer. Glycoconj. J., 18, 841-850.
7. Dall'Olio, F. and Trere, D. (1993) Expression of α2,6-sialylated sugar chains in normal and neoplastic colon tissues. Detection by digoxigenin-conjugated Sambucus nigra agglutinin. Eur. J. Histochem., 37, 257-265.
8. Dall'Olio, F., Malagolini, N., Di Stefano, G., Minni, F., Marrano, D., and Serafini-Cessi, F. (1989) Increased CMP-NeuAc:Galβ1,4GlcNAc-R α2,6 sialyltransferase activity in human colorectal cancer tissues. Int. J. Cancer, 44, 434-439.
9. Dall'Olio, F., Chiricolo, M., Lollini, P., and Lau, J.T. (1995) Human colon cancer cell lines permanently expressing α2,6- sialylated sugar chains by transfection with rat β-galactoside α2,6 sialyltransferase cDNA. Biochem. Biophys. Res. Commun., 211, 554-561.
10. Dall'Olio, F., Malagolini, N., Guerrini, S., Lau, J.T., and Serafini-Cessi, F. (1996) Differentiation-dependent expression of human β-galactoside α2,6-sialyltransferase mRNA in colon carcinoma CaCo-2 cells. Glycoconj. J., 13, 115-121.
11. Dall'Olio, F., Chiricolo, M., and Lau, J.T. (1999) Differential expression of the hepatic transcript of β-galactoside α2,6-sialyltransferase in human colon cancer cell lines. Int. J. Cancer, 81, 243-247.
12. Dall'Olio, F., Chiricolo, M., Ceccarelli, C., Minni, F., Marrano, D., and Santini, D. (2000) β-Galactoside α2,6 sialyltransferase in human colon cancer: contribution of multiple transcripts to regulation of enzyme activity and reactivity with Sambucus nigra agglutinin. Int. J. Cancer, 88, 58-65.
13. Dall'Olio, F., Chiricolo, M., Mariani, E., and Facchini, A. (2001) Biosynthesis of the cancer-related sialyl-α2,6-tactosaminyl epitope in colon cancer cell lines expressing β-galactoside α2,6- sialyltransferase under a constitutive promoter. Eur. J. Biochem., 268, 5876-5884.
14. Dalziel, M., Lemaire, S., Ewing, J., Kobayashi, L., and Lau, J.T. (1999) Hepatic acute phase induction of murine β-galactoside α2,6 sialyltransferase (ST6Gal I) is IL-6 dependent and mediated by elevation of exon H-containing class of transcripts. Glycobiology, 9, 1003-1008.
15. Fiorentino, M., D'Errico, A., Altimari, A., Barozzi, C., and Grigioni, W.F. (1999) High levels of BCL-2 messenger RNA detected by in situ hybridization in human hepatocellular and cholangiocellular carcinomas. Diagn. Mol. Pathol., 8, 189-194.
16. Grundmann, U., Nerlich, C., Rein, T., and Zettlmeissl, G. (1990) Complete cDNA sequence encoding human β-galactoside α-2,6-sialyltransferase. Nucleic Acids Res., 18, 667.
17. Harduin-Lepers, A., Vallejo-Ruiz, V., Krzewinski-Recchi, M., Samyn-Petit, B., Julien, S., and Delannoy, P. (2001) The human sialyltransferase family. Biochimie, 83, 727-737.
18. Jain, N., Sudhakar, C., and Das, M.R. (1993) Regulation of expression of β-galactoside α 2,6-sialyltransferase in a rat tumor, Zajdela ascitic hepatoma. FEBS Lett., 317, 147-151.
19. Kaneko, Y., Yamamoto, H., Colley, K.J., and Moskal, J.R. (1995) Expression of Gal β1,4GlcNAc α2,6-sialyltransferase and α2,6-linked sialoglycoconjugates in normal human and rat tissues. J. Histochem. Cytochem., 43, 945-954.
20. Kaplan, H.A., Woloski, B.M., Hellman, M., and Jamieson, J.C. (1983) Studies on the effect of inflammation on rat liver and serum sialyltransferase. Evidence that inflammation causes release of Gal β1,4GlcNAc α2,6 sialyltransferase from liver. J. Biol. Chem., 258, 11505-11509.
21. Kitagawa, H. and Paulson, J.C. (1994) Differential expression of five sialyltransferase genes in human tissues. J. Biol. Chem., 269, 17872-17878.
22. Krzewinski-Recchi, M.A., Julien, S., Juliant, S., Teintenier-Lelievre, M., Samyn-Petit, B., Montiel, M.D., Mir, A.M., Cerutti, M., Harduin-Lepers, A., and Delannoy, P. (2003) Identification and functional expression of a second human beta-galactoside alpha2,6-sialyltransferase, ST6Gal II. Eur. J. Biochem., 270, 950-961.
23. Lee, E.U., Roth, J., and Paulson, J.C. (1989) Alteration of terminal glycosylation sequences on N-linked oligosaccharides of Chinese hamster ovary cells by expression of β-galactoside α2,6-sialyltransferase. J. Biol. Chem., 264, 13848-13855.
24. Lo, N.W. and Lau, J.T. (1996) Transcription of the β-galactoside α2,6-sialyltransferase gene in B lymphocytes is directed by a separate and distinct promoter. Glycobiology, 6, 271-279.
25. Miyagi, T., Koseki, M., and Tsuiki, S. (1988) Comparative study of the levels of sialyltransferases responsible for the formation of sugar chains in glycoproteins and gangliosides in rat liver and hepatomas. Jpn. J. Cancer Res., 79, 742-749.
26. Murayama, T., Zuber, C., Seelentag, W.K., Li, W.P., Kemmner, W., Heitz, P.U., and Roth, J. (1997) Colon carcinoma glycoproteins carrying α 2,6-linked sialic acid reactive with Sambucus nigra agglutinin are not constitutively expressed in normal human colon mucosa and are distinct from sialyl-Tn antigen. Int. J. Cancer, 70, 575-581.
27. Ozturk, M. (1999) Genetic aspects of hepatocellular carcinogenesis. Semin. Liver Dis., 19, 235-242.
28. Paulson, J.C., Weinstein, J., and Schauer, A. (1989) Tissue-specific expression of sialyltransferases. J. Biol. Chem., 264, 10931-10934.
29. Pousset, D., Piller, V., Bureaud, N., Monsigny, M., and Piller, F. (1997) Increased α2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma. Cancer Res., 57, 4249-4256.
30. Recchi, M.A., Hebbar, M., Hornez, L., Harduin-Lepers, A., Peyrat, J.P., and Delannoy, P. (1998) Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. Cancer Res., 58, 4066-4070.
31. Schauer, R. (2000) Achievements and challenges of sialic acid research. Glycoconj. J., 17, 485-499.
32. Shah, S., Lance, P., Smith, T.J., Berenson, C.S., Cohen, S.A., Horvath, P.J., Lau, J.T., and Baumann, H. (1992) n-Butyrate reduces the expression of β-galactoside α2,6-sialyltransferase in Hep G2 cells. J. Biol. Chem., 267, 10652-10658.
33. Shibuya, N., Goldstein, I.J., Broekaert, W.F., Nsimba-Lubaki, M., Peeters, B., and Peumans, W.J. (1987) The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu 5Ac(α2-6)Gal/GalNAc sequence. J. Biol. Chem., 262, 1596-1601.
34. Stamenkovic, I., Asheim, H.C., Deggerdal, A., Blomhoff, H.K., Smeland, E.B., and Funderud, S. (1990) The B cell antigen CD75 is a cell surface sialytransferase. J. Exp. Med., 172, 641-643.
35. Svensson, E.C., Soreghan, B., and Paulson, J.C. (1990) Organization of the β-galactoside α2,6-sialyltransferase gene. Evidence for the transcriptional regulation of terminal glycosylation. J. Biol. Chem., 265, 20863-20868.
36. Taatjes, D.J., Roth, J., Weinstein, J., and Paulson, J.C. (1988) Post-Golgi apparatus localization and regional expression of rat intestinal sialyltransferase detected by immunoelectron microscopy with polypeptide epitope-purified antibody. J. Biol. Chem., 263, 6302-6309.
37. Takashima, S., Tsuji, S., and Tsujimoto, M. (2002) Characterization of the second type of human β-galactoside α2,6-sialyltransferase (ST6Gal II), which sialylates Galβ1,4GlcNAc structures on oligosaccharides preferentially. Genomic analysis of human sialyltransferase genes. J. Biol. Chem., 277, 45719-45728.
38. Tsuji, S., Datta, A.K., and Paulson, J.C. (1996) Systematic nomenclature for sialyltransferases [letter]. Glycobiology, 6, v-vii.
39. Varki, A. (1993) Biological roles of oligosaccharides: all of the theories are correct. Glycobiology, 3, 97-130.
40. Vertino-Bell, A., Ren, J., Black, J.D., and Lau, J.T. (1994) Developmental regulation of β-galactoside α2,6-sialyltransferase in small intestine epithelium. Dev. Biol., 165, 126-136.
41. Wang, X., O'Hanlon, T.P., Young, R.F., and Lau, J.T. (1990) Rat β-galactoside α2,6-sialyltransferase genomic organization: alternate promoters direct the synthesis of liver and kidney transcripts. Glycobiology, 1, 25-31.
42. Wang, X., Vertino, A., Eddy, R.L., Byers, M.G., Jani-Sait, S.N., Shows, T.B., and Lau, J.T. (1993) Chromosome mapping and organization of the human β-galactoside α2,6-sialyltransferase gene. Differential and cell-type specific usage of upstream exon sequences in B-lymphoblastoid cells. J. Biol. Chem., 268, 4355-4361.
43. Wang, X.C., O'Hanlon, T.P., and Lau, J.T. (1989) Regulation of β-galactoside α2,6-sialyltransferase gene expression by dexamethasone. J. Biol. Chem., 264, 1854-1859.
44. Weinstein, J., de Souza e Silva, U., and Paulson, J.C. (1982a) Purification of a Gal β1,4GlcNAc α2,6 sialyltransferase and a Gal β1,3(4)GlcNAc α2,3 sialyltransferase to homogeneity from rat liver. J. Biol. Chem., 257, 13835-13844.
45. Weinstein, J., de Souza e Silva, U., and Paulson, J.C. (1982b) Sialylation of glycoprotein oligosaccharides N-linked to asparagine. Enzymatic characterization of a Gal β1,3(4)GlcNAc α2,3 sialyltransferase and a Gal β1,4GlcNAc α 2,6 sialyltransferase from rat liver. J. Biol. Chem., 257, 13845-13853.
46. 2-terminal signal anchor. J. Biol. Chem., 262, 17735-17743.